Inanovate

company

About

Inanovate develops a longitudinal assay screening technology for the detection and measurement of multiple proteins.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$255.85K
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Active

Inanovate develops a longitudinal assay screening technology for the detection and measurement of multiple proteins. It offers to test and benchmark Bio-ID that consists of a compact bench-top analyzer and disposable test cartridges for precisely measuring the concentration of multiple disease-related biological molecules from patient blood samples.

The company was founded in 2006 and is headquartered in Sioux Falls, South Dakota.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$255.85K
Inanovate has raised a total of $255.85K in funding over 2 rounds. Their latest funding was raised on Dec 21, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 21, 2020 Grant $255.85K 1 National Science Foundation Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Inanovate has made 1 investments. Their most recent investment was on Jul 14, 2016, when Revolut raised 0.
Date Company Name
Round Money Raised Industry Lead Investor
Jul 14, 2016 Revolut
Series A Banking

Investors

Number of Lead Investors
Number of Investors
1
1
Inanovate is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant